Your browser doesn't support javascript.
loading
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Driessen, Christoph; Duchosal, Michel A; Heim, Dominik; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Schmidt, Adrian; Taverna, Christian; Zander, Thilo; Renner, Christoph.
Afiliação
  • Samaras P; Oncology Centre Hirslanden and Zurich, Switzerland.
  • Bargetzi M; Centre of Oncology/Haematology and Transfusion Medicine, Cantonal Hospital Aarau, Switzerland.
  • Betticher DC; Clinics of Medical Oncology, HFR Fribourg Cantonal Hospital, Fribourg, Switzerland.
  • Driessen C; Division of Oncology/Haematology, Cantonal Hospital St Gallen, Switzerland.
  • Duchosal MA; Service and Central Laboratory of Haematology, University Hospital of Lausanne, Switzerland.
  • Heim D; Department of Haematology, University Hospital Basel, Switzerland.
  • Ketterer N; Clinic Bois-Cerf, Onco-haematology, Lausanne, Switzerland.
  • Lerch E; Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland.
  • Matthes T; Division of Haematology, University Hospital Geneva, Switzerland.
  • Mey U; Medical Oncology and Haematology, Cantonal Hospital Graubuenden, Chur, Switzerland.
  • Pabst T; Department of Medical Oncology, University Hospital of Bern, Switzerland.
  • Schmidt A; Clinic of Medical Oncology and Haematology, City Hospital Triemli, Zurich, Switzerland.
  • Taverna C; Oncology/Haematology, Cantonal Hospital Münsterlingen, Switzerland.
  • Zander T; Department of Medical Oncology, Cantonal Hospital Lucerne, Switzerland.
  • Renner C; Oncology Centre Hirslanden and Zurich, Switzerland.
Swiss Med Wkly ; 149: w20031, 2019 Mar 25.
Article em En | MEDLINE | ID: mdl-30943308
This update on plasma cell myeloma has been elaborated by a Swiss expert panel as a result of the plethora of new data on the treatment of plasma cell myeloma reported recently. It adds new insights to the more extensive review that was published 3 years ago and may help clinicians on decision making for their patients. The new recommendations for distinguishing plasma cell myeloma from smouldering myeloma are briefly presented, including a section on contemporary imaging studies with this respect. Former panel recommendations that remain unchanged by new results will not be discussed in detail as the major focus of this review is on treatment-relevant new developments.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Swiss Med Wkly Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suíça País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Swiss Med Wkly Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suíça País de publicação: Suíça